EGLONYL (Sulpiride, Dogmatil, Dolmatil) is an antipsychotic, used to relieve the symptoms of schizophrenia. Schizophrenia is a mental health problem which affects your thoughts, feelings or behaviours. Symptoms of schizophrenia include hearing, seeing, or sensing things that are not real, having mistaken beliefs, and feeling unusually suspicious. Sulpiride works on the balance of chemical substances acting in your brain.
- Treatment of psychosis associated with schizophrenia.
- Major depressive disorder.
- Sometime at low dosage used to treat anxiety and mild depression.
GUARANTEE & EXPIRY DAY
100% original from the French Sanofi Aventis and Delpharm Dijon. Expiry date up to 02.2024.
Sulpiride first appeared in published literature in 1967. Clinical studies show a greater effect on treating the negative symptoms of schizophrenia rather than positive symptoms at low doses, though the effects are more equal at higher doses. Sulpiride is not approved by the FDA, Health Canada, or the EMA; though it is approved in individual European countries.
SIDE EFFECTS & PRECAUTIONS
Please see medicines.org.uk
PACKAGE & DOSAGE
The medication is taken orally.
Active ingredient: Sulpiride - 200 mg per tablet.
Excipients: core: potato starch, lactose monohydrate, methylcellulose, colloidal silicon dioxide, talc, magnesium stearate.
Tablets are taken 1-3 times a day with a small amount of liquid, regardless of the meal.
It is not recommended to take the drug in the second half of the day (after 4 pm) due to the increased activity level.
Acute and chronic schizophrenia, acute delirious psychosis, depression: the daily dose is from 200 to 1000 mg, divided into several doses.
Neuroses and anxiety in adult patients: the daily dose is 50 to 150 mg for a maximum of 4 weeks.
It is recommended to store the medicine in a dark place at a temperature not exceeding 25°C.
Ask us any questions about Eglonyl.